Author
Listed:
- Patrik Eickhoff
(The Institute of Cancer Research)
- Ceylan Sonmez
(Linköping University)
- Charlotte E. L. Fisher
(The Institute of Cancer Research)
- Oviya Inian
(The Institute of Cancer Research)
- Theodoros I. Roumeliotis
(The Institute of Cancer Research)
- Angela dello Stritto
(Linköping University)
- Jörg Mansfeld
(The Institute of Cancer Research)
- Jyoti S. Choudhary
(The Institute of Cancer Research)
- Sebastian Guettler
(The Institute of Cancer Research)
- Francisca Lottersberger
(Linköping University)
- Max E. Douglas
(The Institute of Cancer Research)
Abstract
During classical non-homologous end joining (cNHEJ), DNA-dependent protein kinase (DNA-PK) encapsulates free DNA ends, forming a recruitment platform for downstream end-joining factors including ligase 4 (LIG4)1. DNA-PK can also bind telomeres and regulate their resection2–4, but does not initiate cNHEJ at this position. How the end-joining process is regulated in this context-specific manner is currently unclear. Here we show that the shelterin components TRF2 and RAP1 form a complex with DNA-PK that directly represses its end-joining function at telomeres. Biochemical experiments and cryo-electron microscopy reveal that when bound to TRF2, RAP1 establishes a network of interactions with KU and DNA that prevents DNA-PK from recruiting LIG4. In mouse and human cells, RAP1 is redundant with the Apollo nuclease in repressing cNHEJ at chromosome ends, demonstrating that the inhibition of DNA-PK prevents telomere fusions in parallel with overhang-dependent mechanisms. Our experiments show that the end-joining function of DNA-PK is directly and specifically repressed at telomeres, establishing a molecular mechanism for how individual linear chromosomes are maintained in mammalian cells.
Suggested Citation
Patrik Eickhoff & Ceylan Sonmez & Charlotte E. L. Fisher & Oviya Inian & Theodoros I. Roumeliotis & Angela dello Stritto & Jörg Mansfeld & Jyoti S. Choudhary & Sebastian Guettler & Francisca Lottersbe, 2025.
"Chromosome end protection by RAP1-mediated inhibition of DNA-PK,"
Nature, Nature, vol. 642(8069), pages 1090-1096, June.
Handle:
RePEc:nat:nature:v:642:y:2025:i:8069:d:10.1038_s41586-025-08896-1
DOI: 10.1038/s41586-025-08896-1
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:642:y:2025:i:8069:d:10.1038_s41586-025-08896-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.